Clincosm LogoSign in Get a demo

Recurrent Breast Cancer

Showing 51 - 75 of 115
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

HER2-negative Breast Cancer, Inflammatory Breast Cancer, Male Breast Cancer Trial in Philadelphia (Romidepsin, Abraxane)

Terminated
Has Results
  • HER2-negative Breast Cancer
  • +4 more
  • Philadelphia, Pennsylvania
    Thomas Jefferson University
Dec 4, 2017

Estrogen Receptor-negative Breast Cancer, HER2-negative Breast Cancer, Hereditary Breast/Ovarian Cancer - BRCA1 Trial in Seattle

Completed
  • Estrogen Receptor-negative Breast Cancer
  • +8 more
  • Seattle, Washington
    Fred Hutchinson Cancer Research Center/University of Washington
Aug 8, 2017

HER2-positive Breast Cancer, Male Breast Cancer, Recurrent Breast Cancer Trial in Seattle (pegylated liposomal doxorubicin HCl,

Completed
Has Results
  • HER2-positive Breast Cancer
  • +3 more
  • pegylated liposomal doxorubicin hydrochloride
  • +2 more
  • Seattle, Washington
    Fred Hutchinson Cancer Research Center/University of Washington
Jun 27, 2017

Arthralgia, Musculoskeletal Complications, Pain Trial in Seattle (drug, dietary supplement, other, procedure)

Completed
Has Results
  • Arthralgia
  • +8 more
  • Seattle, Washington
    Fred Hutchinson Cancer Research Center/University of Washington
Jun 10, 2017

CNS Metastases, Leptomeningeal Metastases, Recurrent Breast Cancer Trial in Seattle (methotrexate, liposomal cytarabine,

Completed
Has Results
  • Central Nervous System Metastases
  • +4 more
  • Seattle, Washington
    Fred Hutchinson Cancer Research Center/University of Washington
Jun 7, 2017

Estrogen Receptor Negative Breast Cancer, Human Epidermal Growth Factor 2 Negative Carcinoma of Breast, Triple Negative Breast

Terminated
Has Results
  • Estrogen Receptor Negative Breast Cancer
  • +5 more
  • Birmingham, Alabama
  • +15 more
May 22, 2017

HER2-positive Breast Cancer, Male Breast Cancer, Recurrent Breast Cancer Trial in Seattle (biological, procedure, drug, other)

Completed
Has Results
  • HER2-positive Breast Cancer
  • +3 more
  • HER-2/neu peptide vaccine
  • +5 more
  • Seattle, Washington
    Fred Hutchinson Cancer Research Center/University of Washington
Apr 17, 2017

Ductal Breast Carcinoma in Situ, Lobular Breast Carcinoma in Situ, Recurrent Breast Cancer Trial (breast reconstruction,

Withdrawn
  • Ductal Breast Carcinoma in Situ
  • +9 more
  • breast reconstruction
  • intraoperative imaging
  • (no location specified)
Apr 12, 2017

HER2-positive Breast Cancer, Male Breast Cancer, Recurrent Breast Cancer Trial in Seattle (HER-2/neu peptide vaccine)

Terminated
  • HER2-positive Breast Cancer
  • +3 more
  • HER-2/neu peptide vaccine
  • Seattle, Washington
    Fred Hutchinson Cancer Research Center/University of Washington
Apr 9, 2017

Estrogen Receptor-positive Breast Cancer, Recurrent Breast Cancer, Stage IV Breast Cancer Trial in Saint Louis (BKM120,

Completed
  • Estrogen Receptor-positive Breast Cancer
  • +2 more
  • Saint Louis, Missouri
    Washington University School of Medicine
Jan 23, 2017

Recurrent Breast Cancer, Stage IIIB Breast Cancer, Stage IIIC Breast Cancer Trial in Detroit (tanespimycin, laboratory biomarker

Terminated
Has Results
  • Recurrent Breast Cancer
  • +3 more
  • Detroit, Michigan
    Barbara Ann Karmanos Cancer Institute
Nov 18, 2016

Recurrent Breast Cancer, Stage IV Breast Cancer Trial in Seoul ([18F]fluoroestradiol (FES))

Completed
  • Recurrent Breast Cancer
  • Stage IV Breast Cancer
  • [18F]fluoroestradiol (FES)
  • Seoul, Korea, Republic of
    Asan Medical Center
Dec 7, 2016

Stage IV Breast Cancer, Recurrent Breast Cancer Trial (tamoxifen, trastuzumab)

Withdrawn
  • Stage IV Breast Cancer
  • Recurrent Breast Cancer
  • (no location specified)
Jul 11, 2016

Human Epidermal Growth Factor 2 Negative Carcinoma of Breast, Male Breast Cancer, Recurrent Breast Cancer Trial in Tucson (drug,

Completed
  • Human Epidermal Growth Factor 2 Negative Carcinoma of Breast
  • +4 more
  • Tucson, Arizona
    Arizona Cancer Center
Apr 20, 2016

Fallopian Tube Cancer, Female Reproductive Cancer, Recurrent Breast Cancer Trial in United States (ixabepilone, pegylated

Completed
Has Results
  • Fallopian Tube Cancer
  • +6 more
  • Farmington, Connecticut
  • +4 more
Feb 11, 2016

Male Breast Cancer, Recurrent Breast Cancer, Stage IV Breast Cancer Trial in Boston (cediranib maleate, laboratory biomarker

Completed
Has Results
  • Male Breast Cancer
  • +2 more
  • cediranib maleate
  • laboratory biomarker analysis
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
Dec 3, 2015

Advanced Breast Cancer, Stage 4 Breast Cancer, Recurrent Breast Cancer Trial in Cleveland (T-PAT, Surveys)

Completed
  • Advanced Breast Cancer
  • +2 more
  • T-PAT
  • Surveys
  • Cleveland, Ohio
    Case Medical Center, University Hospitals Seidman Cancer Center,
Nov 25, 2015

Anxiety Disorder, Depression, Fatigue Trial in Columbus (other, procedure, behavioral)

Completed
  • Anxiety Disorder
  • +19 more
  • questionnaire administration
  • +5 more
  • Columbus, Ohio
    Ohio State University Medical Center
Oct 8, 2015

Radiation Toxicity, Recurrent Breast Cancer, Stage I Breast Cancer Trial in Westlake (alkaline water, distilled water, external

Completed
Has Results
  • Radiation Toxicity
  • +7 more
  • alkaline water
  • +2 more
  • Westlake, Ohio
    University Hospitals-Westlake
Jun 1, 2015

Male Breast Cancer, Recurrent Breast Cancer, Stage IV Breast Cancer Trial in Duarte (vorinostat, laboratory biomarker analysis)

Terminated
Has Results
  • Male Breast Cancer
  • +2 more
  • Duarte, California
    City of Hope
Mar 6, 2015

Recurrent Breast Cancer, Stage IIIB Breast Cancer, Stage IV Breast Cancer Trial in Columbus (suramin, paclitaxel,

Completed
Has Results
  • Recurrent Breast Cancer
  • +2 more
  • Columbus, Ohio
    Ohio State University Medical Center
Mar 3, 2015

HER2-positive Breast Cancer, Recurrent Breast Cancer, Recurrent NSCLC Trial in Seattle (drug, biological, other)

Completed
  • HER2-positive Breast Cancer
  • +8 more
  • ex vivo-expanded HER2-specific T cells
  • +4 more
  • Seattle, Washington
    Fred Hutchinson Cancer Research Center/University of Washington
Nov 7, 2014

Male Breast Cancer, Recurrent Breast Cancer, Stage IV Breast Cancer Trial in Sacramento (GTI-2040, capecitabine)

Completed
Has Results
  • Male Breast Cancer
  • +2 more
  • Sacramento, California
    University of California Davis Cancer Center
Oct 24, 2014

HER2-positive Breast Cancer, Male Breast Cancer, Recurrent Breast Cancer Trial in Sioux Falls, Madison (Akt inhibitor MK2206,

Completed
  • HER2-positive Breast Cancer
  • +6 more
  • Akt inhibitor MK2206
  • +3 more
  • Sioux Falls, South Dakota
  • +1 more
Oct 22, 2014

Depression, Post-traumatic Stress Disorder, Recurrent Breast Cancer Trial in Nevada City, Stanford (support group therapy,

Completed
  • Depression
  • +9 more
  • support group therapy
  • educational intervention
  • Nevada City, California
  • +1 more
Oct 15, 2014